All Stories

  1. How to evaluate agreement between quantitative measurements

    Article • Radiotherapy and Oncology, September 2019, Elsevier

    Dr Annette Kopp-Schneider

  2. Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control

    Article • Biometrical Journal, July 2019, Wiley

    Dr Annette Kopp-Schneider

  3. Monitoring futility and efficacy in phase II trials with Bayesian posterior distributions-A calibration approach

    Article • Biometrical Journal, September 2018, Wiley

    Dr Annette Kopp-Schneider

  4. Multiple-rater kappas for binary data: Models and interpretation

    Article • Biometrical Journal, December 2017, Wiley

    Dr Annette Kopp-Schneider

  5. Parametric modeling and optimal experimental designs for estimating isobolograms for drug interactions in toxicology

    Article • Journal of Biopharmaceutical Statistics, November 2017, Taylor & Francis

    Dr Annette Kopp-Schneider

  6. Testing R Code R. Cotton  Boca Raton, FL: Chapman & Hall/CRC Press. 178 pages, ISBN 978-1-4987-6365-3

    Article • Biometrical Journal, September 2017, Wiley

    Dr Annette Kopp-Schneider

  7. Addressing small sample size bias in multiple-biomarker trials: Inclusion of biomarker-negative patients and Firth correction

    Article • Biometrical Journal, August 2017, Wiley

    Dr Annette Kopp-Schneider

  8. Functional analysis of high-content high-throughput imaging data

    Article • Journal of Applied Statistics, September 2016, Taylor & Francis

    Dr Annette Kopp-Schneider

  9. Cell type-specific expression and localization of cytochrome P450 isoforms in tridimensional aggregating rat brain cell cultures

    Article • Toxicology in Vitro, December 2015, Elsevier

    Dr Annette Kopp-Schneider

  10. Quantitative in vitro to in vivo extrapolation of tissues toxicity

    Article • Toxicology in Vitro, December 2015, Elsevier

    Dr Annette Kopp-Schneider

  11. Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period

    Article • Toxicology in Vitro, December 2015, Elsevier

    Dr Annette Kopp-Schneider

  12. Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing

    Article • Toxicology in Vitro, December 2015, Elsevier

    Dr Annette Kopp-Schneider

  13. Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation

    Article • Cell Death and Disease, February 2015, Nature

    Dr Annette Kopp-Schneider

  14. Richly Parametrized Linear Models: Additive, Time Series, and Spatial Models Using Random Effects. J. S. Hodges (2014). Boca Raton: Chapman & Hall/CRC Texts in Statistical Science. 431 pages, ISBN: 978-1-4398-6683-2.

    Article • Biometrical Journal, October 2014, Wiley

    Dr Annette Kopp-Schneider

  15. Statistical strategies for averaging EC50 from multiple dose–response experiments

    Article • Archives of Toxicology, October 2014, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  16. A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy

    Article • Cell Death and Disease, September 2014, Nature

    Dr Annette Kopp-Schneider

  17. Quantitative Emphysema Distribution in Anatomic and Non-anatomic Lung Regions

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, September 2014, Taylor & Francis

    Dr Annette Kopp-Schneider

  18. Optimal experimental designs for dose–response studies with continuous endpoints

    Article • Archives of Toxicology, August 2014, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  19. Reproducible Research with R and RStudio. C. Gandrud (2013). Chapman & Hall/CRC: The R Series. 294 pages, ISBN-13: 978-1466572843.

    Article • Biometrical Journal, May 2014, Wiley

    Dr Annette Kopp-Schneider

  20. Genomic Clinical Trials and Predictive Medicine. R. M. Simon (2013). New York: Cambridge University Press. 144 pages, ISBN: 978-1-107-40135-8.

    Article • Biometrical Journal, May 2014, Wiley

    Dr Annette Kopp-Schneider

  21. Magnetic Resonance Imaging Detects Changes in Structure and Perfusion, and Response to Therapy in Early Cystic Fibrosis Lung Disease

    Article • American Review of Respiratory Disease, April 2014, American Thoracic Society

    Dr Annette Kopp-Schneider

  22. Summarizing EC50 estimates from multiple dose-response experiments: A comparison of a meta-analysis strategy to a mixed-effects model approach

    Article • Biometrical Journal, January 2014, Wiley

    Dr Annette Kopp-Schneider

  23. GRHL1 Acts as Tumor Suppressor in Neuroblastoma and Is Negatively Regulated by MYCN and HDAC3

    Article • Cancer Research, January 2014, American Association for Cancer Research (AACR)

    Dr Annette Kopp-Schneider

  24. Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis

    Article • Radiation Oncology, January 2014, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  25. Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience

    Article • European Journal of Nuclear Medicine and Molecular Imaging, December 2013, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  26. Validation of Fourier decomposition MRI with dynamic contrast-enhanced MRI using visual and automated scoring of pulmonary perfusion in young cystic fibrosis patients

    Article • European Journal of Radiology, December 2013, Elsevier

    Dr Annette Kopp-Schneider

  27. Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla

    Article • European Radiology, October 2013, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  28. Transcriptomic Hepatotoxicity Signature of Chlorpromazine after Short- and Long-Term Exposure in Primary Human Sandwich Cultures

    Article • Drug Metabolism and Disposition, August 2013, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Annette Kopp-Schneider

  29. Comparative analysis of eight cytotoxicity assays evaluated within the ACuteTox Project

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  30. Data management in large-scale collaborative toxicity studies: How to file experimental data for automated statistical analysis

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  31. Design of a testing strategy using non-animal based test methods: Lessons learnt from the ACuteTox project

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  32. Evaluation of aggregating brain cell cultures for the detection of acute organ-specific toxicity

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  33. Selection of test methods to be included in a testing strategy to predict acute oral toxicity: An approach based on statistical analysis of data collected in phase 1 of the ACuteTox project

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  34. The value of selected in vitro and in silico methods to predict acute oral toxicity in a regulatory context: Results from the European Project ACuteTox

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  35. MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma

    Article • Nucleic Acids Research, April 2013, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  36. Biological and Tumor-Promoting Effects of Dioxin-like and Non-Dioxin-like Polychlorinated Biphenyls in Mouse Liver After Single or Combined Treatment

    Article • Toxicological Sciences, March 2013, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  37. Accuracy and Variability of Semiautomatic Centerline Analysis versus Manual Aortic Measurement Techniques for TEVAR

    Article • European Journal of Vascular and Endovascular Surgery, March 2013, Elsevier

    Dr Annette Kopp-Schneider

  38. Diffusion-weighted imaging in rectal carcinoma patients without and after chemoradiotherapy: A comparative study with histology

    Article • European Journal of Radiology, March 2013, Elsevier

    Dr Annette Kopp-Schneider

  39. Stochastic time‐concentration activity models for cytotoxicity in 3D brain cell cultures

    Article • Theoretical Biology and Medical Modelling, January 2013, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  40. The role of perfusion effects in monitoring of chemoradiotherapy of rectal carcinoma using diffusion-weighted imaging

    Article • Cancer Imaging, January 2013, E-MED LTD

    Dr Annette Kopp-Schneider

  41. Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2

    Article • International Journal of Cancer, October 2012, Wiley

    Dr Annette Kopp-Schneider

  42. The impact of data transformations on concentration–response modeling

    Article • Toxicology Letters, September 2012, Elsevier

    Dr Annette Kopp-Schneider

  43. Accuracy of MRI with an endorectal coil for staging endometrial cancer

    Article • Acta Radiologica, June 2012, SAGE Publications

    Dr Annette Kopp-Schneider

  44. Morphologic and functional scoring of cystic fibrosis lung disease using MRI

    Article • European Journal of Radiology, June 2012, Elsevier

    Dr Annette Kopp-Schneider

  45. Proposal for a New Prognostic Score for Linac-Based Radiosurgery in Cerebral Arteriovenous Malformations

    Article • International Journal of Radiation Oncology*Biology*Physics, June 2012, Elsevier

    Dr Annette Kopp-Schneider

  46. Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC

    Article • BMC Cancer, March 2012, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  47. Epstein-Barr Virus Stimulates Torque Teno Virus Replication: A Possible Relationship to Multiple Sclerosis

    Article • PLoS ONE, February 2012, PLOS

    Dr Annette Kopp-Schneider

  48. An Adaptive Group Sequential Phase II Design to Compare Treatments for Survival Endpoints in Rare Patient Entities

    Article • Journal of Biopharmaceutical Statistics, January 2012, Taylor & Francis

    Dr Annette Kopp-Schneider

  49. Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial

    Article • Radiation Oncology, January 2012, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  50. The Feasibility of Low Mechanical Index Contrast Enhanced Ultrasound (CEUS) in Distinguishing Malignant from Benign Thoracic Lesions

    Article • Ultrasound in Medicine & Biology, November 2011, Elsevier

    Dr Annette Kopp-Schneider

  51. High-resolution phase-contrast MRI of aortic and pulmonary blood flow during rest and physical exercise using a MRI compatible bicycle ergometer

    Article • European Journal of Radiology, October 2011, Elsevier

    Dr Annette Kopp-Schneider

  52. Repeatability and Reproducibility of Quantitative Whole-lung Perfusion Magnetic Resonance Imaging

    Article • Journal of Thoracic Imaging, August 2011, Wolters Kluwer Health

    Dr Annette Kopp-Schneider

  53. Concordance Analysis

    Article • Deutsches Ärzteblatt international, July 2011, Deutscher Arzte-Verlag GmbH

    Dr Annette Kopp-Schneider

  54. E6 and E7 from Beta Hpv38 Cooperate with Ultraviolet Light in the Development of Actinic Keratosis-Like Lesions and Squamous Cell Carcinoma in Mice

    Article • PLoS Pathogens, July 2011, PLOS

    Dr Annette Kopp-Schneider

  55. Robust biclustering by sparse singular value decomposition incorporating stability selection

    Article • Bioinformatics, June 2011, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  56. Fine Tuning of the Threshold of T Cell Selection by the Nck Adapters

    Article • The Journal of Immunology, November 2010, The American Association of Immunologists

    Dr Annette Kopp-Schneider

  57. Glossopharyngeal Insufflation and Pulmonary Hemodynamics in Elite Breath Hold Divers

    Article • Medicine & Science in Sports & Exercise, September 2010, Wolters Kluwer Health

    Dr Annette Kopp-Schneider

  58. Nck adaptors are positive regulators of the size and sensitivity of the T-cell repertoire

    Article • Proceedings of the National Academy of Sciences, August 2010, Proceedings of the National Academy of Sciences

    Dr Annette Kopp-Schneider

  59. Optimization and prevalidation of the in vitro ERα CALUX method to test estrogenic and antiestrogenic activity of compounds

    Article • Reproductive Toxicology, August 2010, Elsevier

    Dr Annette Kopp-Schneider

  60. Time- and Dose-Dependency of Radiographic Normal Tissue Changes of the Lung After Stereotactic Radiotherapy

    Article • International Journal of Radiation Oncology*Biology*Physics, August 2010, Elsevier

    Dr Annette Kopp-Schneider

  61. HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth

    Article • Clinical Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Dr Annette Kopp-Schneider

  62. Application of a two-phenotype color-shift model with heterogeneous growth to a rat hepatocarcinogenesis experiment

    Article • Mathematical Biosciences, April 2010, Elsevier

    Dr Annette Kopp-Schneider

  63. Modelling the genesis and treatment of cancer: The potential role of physiologically based pharmacodynamics

    Article • European Journal of Cancer, January 2010, Elsevier

    Dr Annette Kopp-Schneider

  64. 4D-CT-based target volume definition in stereotactic radiotherapy of lung tumours: Comparison with a conventional technique using individual margins

    Article • Radiotherapy and Oncology, December 2009, Elsevier

    Dr Annette Kopp-Schneider

  65. Toxicogenomic analysis of N-nitrosomorpholine induced changes in rat liver: Comparison of genomic and proteomic responses and anchoring to histopathological parameters

    Article • Toxicology and Applied Pharmacology, December 2009, Elsevier

    Dr Annette Kopp-Schneider

  66. Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI

    Article • European Radiology, September 2009, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  67. “ToxRTool”, a new tool to assess the reliability of toxicological data

    Article • Toxicology Letters, September 2009, Elsevier

    Dr Annette Kopp-Schneider

  68. Respiratory Displacement of the Thoracic Aorta: Physiological Phenomenon With Potential Implications for Thoracic Endovascular Repair

    Article • CardioVascular and Interventional Radiology, May 2009, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  69. Changes of prostate gland volume with and without androgen deprivation after intensity modulated radiotherapy – A follow-up study

    Article • Radiotherapy and Oncology, March 2009, Elsevier

    Dr Annette Kopp-Schneider

  70. Histone Deacetylase 8 in Neuroblastoma Tumorigenesis

    Article • Clinical Cancer Research, January 2009, American Association for Cancer Research (AACR)

    Dr Annette Kopp-Schneider

  71. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia

    Article • Acta Oncologica, January 2009, Taylor & Francis

    Dr Annette Kopp-Schneider

  72. Intrinsic Gating for Small-Animal Computed Tomography: A Robust ECG-Less Paradigm for Deriving Cardiac Phase Information and Functional Imaging

    Article • Circulation Cardiovascular Imaging, November 2008, Wolters Kluwer Health

    Dr Annette Kopp-Schneider

  73. Assessment of thoracic aortic conformational changes by four-dimensional computed tomography angiography in patients with chronic aortic dissection type b

    Article • European Radiology, July 2008, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  74. Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro

    Article • Cancer Letters, June 2008, Elsevier

    Dr Annette Kopp-Schneider

  75. Semi-automated volumetric analysis of lymph node metastases in patients with malignant melanoma stage III/IV-A feasibility study

    Article • European Radiology, February 2008, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  76. Magnetic resonance-compatible-spirometry: principle, technical evaluation and application

    Article • European Respiratory Journal, November 2007, European Respiratory Society (ERS)

    Dr Annette Kopp-Schneider

  77. C4.4A as a candidate marker in the diagnosis of colorectal cancer

    Article • British Journal of Cancer, October 2007, Nature

    Dr Annette Kopp-Schneider

  78. Assessment of Morphological MRI for Pulmonary Changes in Cystic Fibrosis (CF) Patients

    Article • Investigative Radiology, October 2007, Wolters Kluwer Health

    Dr Annette Kopp-Schneider

  79. Comparison of Mode of Action of Four Hepatocarcinogens: A Model-Based Approach

    Article • Toxicological Sciences, May 2007, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  80. TTV infection in colorectal cancer tissues and normal mucosa

    Article • International Journal of Cancer, January 2007, Wiley

    Dr Annette Kopp-Schneider

  81. E6/E7 Expression of Human Papillomavirus Type 20 (HPV-20) and HPV-27 Influences Proliferation and Differentiation of the Skin in UV-Irradiated SKH-hr1 Transgenic Mice

    Article • Journal of Virology, September 2006, ASM Journals

    Dr Annette Kopp-Schneider

  82. Application of a color-shift model with heterogeneous growth to a rat hepatocarcinogenesis experiment

    Article • Mathematical Biosciences, August 2006, Elsevier

    Dr Annette Kopp-Schneider

  83. Investigating the Formation and Growth of α-Particle Radiation-Induced Foci of Altered Hepatocytes: A Model-Based Approach

    Article • Radiation Research, August 2006, Radiation Research Society

    Dr Annette Kopp-Schneider

  84. Comparison of Software Tools to Improve the Detection of Carcinogen Induced Changes in the Rat Liver Proteome by Analyzing SELDI-TOF−MS Spectra

    Article • Journal of Proteome Research, February 2006, American Chemical Society (ACS)

    Dr Annette Kopp-Schneider

  85. Serological analysis of human renal cell carcinoma

    Article • International Journal of Cancer, January 2006, Wiley

    Dr Annette Kopp-Schneider

  86. Reduced Expression of Interleukin-2 Decreases the Frequency of Alopecia Areata Onset in C3H/HeJ Mice

    Article • Journal of Investigative Dermatology, November 2005, Elsevier

    Dr Annette Kopp-Schneider

  87. Origins of the mutational origin of cancer

    Article • International Journal of Epidemiology, July 2005, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  88. Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

    Article • Oncology Research and Treatment, June 2005, Karger Publishers

    Dr Annette Kopp-Schneider

  89. Molecular approaches to the identification of biomarkers of exposure and effect—report of an expert meeting organized by COST Action B15

    Article • Toxicology Letters, April 2005, Elsevier

    Dr Annette Kopp-Schneider

  90. Differential signatures of protein expression in marmoset liver and thymus induced by single-dose TCDD treatment

    Article • Toxicology, January 2005, Elsevier

    Dr Annette Kopp-Schneider

  91. Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis

    Article • Journal of Virology, May 2004, ASM Journals

    Dr Annette Kopp-Schneider

  92. Randomized Clinical Trial: Myths around Elementary Statistical Principles

    Article • Oncology Research and Treatment, January 2004, Karger Publishers

    Dr Annette Kopp-Schneider

  93. Biostatistical Evaluation of Focal Hepatic Preneoplasia

    Article • Toxicologic Pathology, January 2003, SAGE Publications

    Dr Annette Kopp-Schneider

  94. Prevalidation of a Rat Liver Foci Bioassay (RLFB) Based on Results from 1600 Rats: A Study Report

    Article • Toxicologic Pathology, January 2003, SAGE Publications

    Dr Annette Kopp-Schneider

  95. Deviation from Additivity in Mixture Toxicity: Relevance of Nonlinear Dose-Response Relationships and Cell Line Differences in Genotoxicity Assays with Combinations of Chemical Mutagens and -Radiation

    Article • Environmental Health Perspectives, December 2002, Environmental Health Perspectives

    Dr Annette Kopp-Schneider

  96. Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin

    Article • Oncology Research and Treatment, November 2002, Karger Publishers

    Dr Annette Kopp-Schneider

  97. Woodchuck hepatitis virus replication and antigen expression gradually decrease in preneoplastic hepatocellular lineages

    Article • Journal of Hepatology, October 2002, Elsevier

    Dr Annette Kopp-Schneider

  98. Incorporating phenotype-dependent growth rates into the color-shift model for preneoplastic hepatocellular lesions

    Article • Mathematical Biosciences, September 2002, Elsevier

    Dr Annette Kopp-Schneider

  99. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization

    Article • British Journal of Cancer, November 2001, Nature

    Dr Annette Kopp-Schneider

  100. Modeling cancer detection: tumor size as a source of information on unobservable stages of carcinogenesis

    Article • Mathematical Biosciences, June 2001, Elsevier

    Dr Annette Kopp-Schneider

  101. Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma

    Article • Gut, January 2001, BMJ

    Dr Annette Kopp-Schneider

  102. A model for hepatocarcinogenesis with clonal expansion of three successive phenotypes of preneoplastic cells

    Article • Mathematical Biosciences, December 2000, Elsevier

    Dr Annette Kopp-Schneider

  103. Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks

    Article • Journal of Hepatology, October 2000, Wiley

    Dr Annette Kopp-Schneider

  104. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism

    Article • Carcinogenesis, January 2000, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  105. Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay

    Article • Toxicological Sciences, May 1999, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  106. Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine

    Article • Carcinogenesis, December 1998, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  107. Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: Suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2

    Article • Molecular Carcinogenesis, September 1998, Wiley

    Dr Annette Kopp-Schneider

  108. Statistical models for low dose exposure

    Article • Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, September 1998, Elsevier

    Dr Annette Kopp-Schneider

  109. A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic events

    Article • Mathematical Biosciences, March 1998, Elsevier

    Dr Annette Kopp-Schneider

  110. Carcinogenesis models for risk assessment

    Article • Statistical Methods in Medical Research, April 1997, SAGE Publications

    Dr Annette Kopp-Schneider

  111. Calculating tumor incidence rates in stochastic models of carcinogenesis

    Article • Mathematical Biosciences, July 1996, Elsevier

    Dr Annette Kopp-Schneider

  112. Modeling the Number and Size of Hepatic Focal Lesions Following Exposure to 2,3,7,8-TCDD

    Article • Toxicology and Applied Pharmacology, May 1996, Elsevier

    Dr Annette Kopp-Schneider

  113. Effects of low doses of N -nitrosomorpholine on the development of early stages of hepatocarcinogenesis

    Article • Carcinogenesis, January 1995, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  114. Carcinoma formation in NMRI mouse skin painting studies is a process suggesting greater than two stages

    Article • Carcinogenesis, January 1995, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  115. Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skin

    Article • Carcinogenesis, January 1995, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  116. Multistage Models of Carcinogenesis: An Approximation for the Size and Number Distribution of Late-Stage Clones

    Article • Risk Analysis, December 1994, Wiley

    Dr Annette Kopp-Schneider

  117. The Exact Formula for Tumor Incidence in the Two-Stage Model

    Article • Risk Analysis, December 1994, Wiley

    Dr Annette Kopp-Schneider

  118. Porphyrin studies in TCDD-exposed workers

    Article • Archives of Toxicology, September 1994, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  119. A stem cell model for carcinogenesis

    Article • Mathematical Biosciences, April 1994, Elsevier

    Dr Annette Kopp-Schneider

  120. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability

    Article • Carcinogenesis, January 1994, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  121. The use of cell proliferation data in modeling of skin carcinogenesis

    Article • Environmental Health Perspectives, December 1993, Environmental Health Perspectives

    Dr Annette Kopp-Schneider

  122. Using cell replication data in mathematical modeling in carcinogenesis

    Article • Environmental Health Perspectives, December 1993, Environmental Health Perspectives

    Dr Annette Kopp-Schneider

  123. Birth and death/differentiation rates of papillomas in mouse skin

    Article • Carcinogenesis, January 1992, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  124. Distinguishing between models of carcinogenesis: The role of clonal expansion

    Article • Fundamental and Applied Toxicology, October 1991, Elsevier

    Dr Annette Kopp-Schneider

  125. A Multistage Model of Carcinogenesis Incorporating DNA Damage and Repair

    Article • Risk Analysis, September 1991, Wiley

    Dr Annette Kopp-Schneider

  126. The application of a multistage model that incorporates DNA damage and repair to the analysis of initiation/promotion experiments

    Article • Mathematical Biosciences, July 1991, Elsevier

    Dr Annette Kopp-Schneider